Related Experiment Video

Updated: Sep 2, 2025

In vitro Organoid Culture of Primary Mouse Colon Tumors
07:33

In vitro Organoid Culture of Primary Mouse Colon Tumors

Published on: May 17, 2013

35.3K

CTPS1 inhibition suppresses proliferation and migration in colorectal cancer cells

Fahong Wu1, Yudong Mao1, Tao Ma2

  • 1Department of General Surgery, Hepatic-biliary-pancreatic Institute, Lanzhou University Second Hospital, Lanzhou, China.

Cell Cycle (Georgetown, Tex.)
|August 1, 2022
PubMed

Insights

Researchers identified CTPS1 as a key biomarker for colorectal cancer (CRC). This protein promotes tumor growth and metastasis, suggesting CTPS1 as a potential therapeutic target for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer-related deaths globally.
  • There is an urgent need for novel diagnostic biomarkers and therapeutic targets for CRC.
  • Understanding CRC progression mechanisms is crucial for improving patient outcomes.

Purpose of the Study:

  • To identify a novel molecular biomarker for colorectal cancer diagnosis.
  • To investigate the role of CTPS1 in CRC progression.
  • To elucidate the molecular pathways regulated by CTPS1 in CRC.

Main Methods:

  • Utilized TCGA and GEO databases for bioinformatics analysis.
  • Performed gene expression analysis using PCR.
  • Verified protein expression and pathway interactions via Western blot.

Main Results:

  • CTPS1 was identified as a potential diagnostic biomarker for CRC.
  • CTPS1 promotes tumor proliferation and metastasis in CRC.
  • CTPS1 regulates CRC progression via cell cycle and p53 pathways, affecting genes like GTSE1 and CDK2.

Conclusions:

  • CTPS1 is a significant diagnostic biomarker for colorectal cancer.
  • CTPS1's role in promoting CRC progression via the p53 pathway is validated.
  • CTPS1 inhibitors represent a potential therapeutic strategy for CRC treatment.
Keywords:
CTPS1Colorectal cancer (CRC)biomarkercell cyclep53

More Related Videos

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)08:42

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)

Published on: June 27, 2025

457
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K